Interactions between trimpex(trimethoprim) and Candesartan (candesartan)
trimethoprim and candesartan (Moderate Drug-Drug)
MANAGEMENT: Serum potassium levels should be checked frequently during concomitant therapy. Trimethoprim should be discontinued if hyperkalemia occurs. Patients should be advised to report any possible symptoms of hyperkalemia such as weakness, listlessness, confusion, tingling of the extremities, or feelings of heaviness in the legs to their physician.






